D espite spending more per patient than any other country, the quality of US health care remains suboptimal. 1 This paradox has led to growing emphasis on the need for value-based health care, which is characterized by the "Triple Aim" of improved patient experience of care, better health of the population, and reduced per capita cost of health care. 2 In cancer care delivery, costs are expected by 2020 to rise to $173 billion per year, 3 in part because of the aging population and high expense associated with caring for geriatric patients. 4 Innovative solutions are needed to transform the health care system. The fragmented nature of US health care delivery and the lack of care coordination between care settings are barriers to high-quality, efficient care. 5 Since the initial reports of lay navigation by Freeman, 6, 7 patient navigation programs have been used to improve access to cancer care, coordinate care delivery, and address barriers to achieving timely, high-quality health care. [8] [9] [10] [11] [12] [13] [14] [15] Navigation programs are expanding nationally and are being included as part of the Commission on Cancer accreditation, 8 ,10 yet the optimal target population and strategy for delivering navigation services are not defined. 8 Historically, most navigation programs focused on early detection and the initial management of cancer. [6] [7] [8] 10, 11 Fewdataexist on navigation for patients with cancer throughout the cancer care continuum (initial, survivorship, and end of life). Evidence for the influence of navigation across this continuum is needed, including for patients at end of life, who are likely to have high symptom burden, experience hospitalizations, and incur higher medical costs. [16] [17] [18] Providing navigation for patients with cancer across the continuum will require workforce expansion. Although nurses are the primary staff for many navigation programs, lay (nonclinical) navigation programs are becoming increasingly prevalent as a low-cost strategy to meet the demand for navigation service in the United States. 8, 19 As part of a Center for Medicare & Medicaid Innovation award, we developed and implemented a lay navigation model, the Patient Care Connect Program (PCCP), for older Medicare beneficiaries with cancer across The University of Alabama at Birmingham (UAB) Health System Cancer Community Network (CCN) . 20 The goal of the program was to meet the Triple Aim 2 of improved health care, better health, and lower costs by integrating lay navigators into the care team. The PCCP navigators aim to proactively identify patient needs, connect patients with resources, coordinate care, and empower patients to take a more active role in their health care. The introduction of lay navigation within the CCN also served as a practice transformation. Navigators, health care personnel, and administrators were engaged in discussions about health care delivery through analysis of shared data. 20 We hypothesized that the PCCP navigation would result in lower health care costs and decreased use of costly medical care, such as emergency department (ED) visits, hospitalizations, and intensive care unit (ICU) admissions. In this analysis, we evaluated the influence of the PCCP by examining trends in these outcomes for navigated patients compared with a matched group of patients who did not receive navigation services.
Methods

Study Design and Oversight
We conducted a secondary analysis of Medicare administrative claims data from January Meaning Lay navigation programs should expand as health systems transition to value-based health care.
assign patients to navigators to initiate contact. Priority was given to high-risk patients, including those with metastatic cancer, high-morbidity cancers (eg, pancreatic, ovarian, and lung), high-risk comorbidities (eg, diabetes, heart failure, and chronic obstructive pulmonary disease), or history of ED visit or hospitalization in the prior month. For this analysis, we defined 2 groups for comparison, the navigated group and a nonnavigated, matched comparison group. The navigated group included patients assigned to a navigator between March 2013 and June 2015. The matched comparison group was selected from nonnavigated patients diagnosed between January 2012 and June 2015. We assigned a pseudo-enrollment date to patients in the comparison group based on the frequency distributions of time from diagnosis to enrollment observed for the PCCP group. 21 We restricted the analysis population to patients who had at least 1 quarter of observation before and 2 quarters of observation after the enrollment or pseudoenrollment date. We further restricted the comparison group to patients who had a pseudo-enrollment date before death and before June 2015.
PCCP Navigation
Details of the PCCP, including patient selection, navigator training, and interventions, have been previously described.
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Briefly, lay navigators were hired from within the community and were required to have a bachelor's degree but were not licensed clinicians, such as nurses or social workers. 
Matching
We matched groups using propensity scores with the following covariates: age at diagnosis, race, sex, cancer acuity (high vs low), phase of care, comorbidity score, baseline cost of care, baseline treatment with chemotherapy, and baseline ED and ICU use. Race was obtained from claims data and categorized as white, black, or other. Cancer acuity was categorized as high (brain, pancreatic, ovarian, lung, and head and neck or any stage IV cancer) or not. Cancer stage was defined using the Surveillance, Epidemiology, and End Results staging. Comorbid conditions were abstracted from claims data from 2012 through 2015 and classified using a weighted score of 0, 1, 2 to 3, or 4 or higher based on the Klabunde modification for comorbidities. [24] [25] [26] We defined the following 3 distinct phases of care at time of enrollment or pseudo-enrollment: initial, survivorship, and end of life. 27 The end-of-life phase was defined as the last 6 months of life. The initial phase included patients within 1 year of diagnosis who were not within the last 6 months of life. The survivorship phase spanned the period between the initial and end-of-life phases. Baseline costs, receipt of chemotherapy, and resource use were calculated for the quarter before enrollment or pseudo-enrollment to account for patients with inherent high use from unmeasured factors.
Once the matched comparison group was identified, we assessed the suitability of the match by examining the overlap of the propensity scores to verify the common support and covariate balance and by using 2-sample t tests and χ 2 tests to evaluate the between-group differences in estimates and proportions. The procedure was repeated varying the covariates used until we obtained overlapping propensity scores with similar proportions of covariates.
Return on Investment
Salaries, including administrative support for the PCCP navigators, ranged from $33 400 to $42 300 per year, and the mean navigator caseload was 152 patients per quarter. 20 For the return on investment, the mean annual salary of $37 850 with 28.0% for fringe benefits, for a total of $48 448, was considered the investment. The return was calculated based on a mean caseload per quarter of 152 patients per navigator multiplied by the difference in the mean decline in Medicare costs of navigated patients compared with nonnavigated patients.
Statistical Analysis
We described characteristics for all beneficiaries in the source population, the navigated group, and the matched nonnavigated comparison group. We used repeatedmeasures generalized linear models to evaluate trends in total cost based on the following covariates: group assignment (group), quarters after enrollment (time), calendar time, and the interaction between group and time. The primary coefficient of interest was the group × time interaction. Furthermore, we examined the differences in the mean quarterly reductions for each type of cost in the following separate generalized linear models: inpatient, outpatient, physician visits (carrier), home health, skilled nursing facility, and hospice. Generalized linear models with the Poisson distribution and log link function with the same set of covariates were used to estimate incidence rate ratios (IRRs) for ED visits, hospitalizations, and ICU admissions and their 95% CIs. In addition, we estimated the modelpredicted counts of ED visits, hospitalizations, and ICU admissions per 1000 observations. For all statistical models, we assessed the multicollinearity of predictor variables using the variance inflation factor and accounted for the correlation of repeated observations. The analyses were performed using statistical software (SAS, version 9.4; SAS Institute Inc). All results were considered statistically significant at P < .05.
Results
Patient Demographics
We identified 12 428 patients, 6214 in the navigated group and 6214 in the matched comparison group (Figure 1) . Before matching, the navigated patients were more likely to have a high-acuity cancer, an advanced stage of cancer, and a higher comorbidity score and to have received chemotherapy during the study than nonnavigated patients ( Table 1) . 20 The mean (SD) age at cancer diagnosis was 75 (7) years (Table 1) . Approximately 12% of the participants were African American. After the match, navigated patients were still more likely to have received chemotherapy during the study (26.5% vs 20.1%, P < .001).
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Medicare Costs
We observed statistically significant group × time interactions for Medicare costs and health care use ( Table 2) . Costs for the navigated group started higher but declined faster than the matched comparison group by $781.29 more per quarter per navigated patient (P < .001), for an estimated $19 million decline per year across the network, ultimately becoming lower for navigated patients after 6 quarters ( Figure 2A ). Inpatient and outpatient costs had the largest between-group quarterly declines, at $294 and $275, respectively, per patient. The greatest mean quarterly cost declines were observed for inpatient costs, which decreased by $522 and $198, respectively, per quarter per patient for navigated and matched comparison groups ( Figure 3) . Quarterly reductions per patient were also observed for outpatient costs ($473 for the navigated group and $194 for the matched comparison group) and physician visit (carrier) costs ($339 for the navigated group and $129 for the matched comparison group), while hospice costs increased ($39 for the navigated group and $36 for the matched comparison group) for navigated patients.
Resource Use
We observed decreases in resource use for the navigated group compared with the matched comparison group ( Table 2 ). The group × time interactions indicate that, compared with the matched comparison group, the navigated group's ED visits decreased by 6.0% more per quarter (IRR, 0.94; 95% CI, 0.92-0.96; P < .001), hospitalizations declined by 7.9% more per quarter (IRR, 0.92; 95% CI, 0.90-0.94; P < .001), and ICU admissions were reduced by 10.6% more per quarter (IRR, 0.90; 95% CI, 0.86-0.94; P < .001). Figure 2B , C, and D show the changes in predicted counts (per 1000 observations) for ED visits, hospitalizations, and ICU admissions.
Return on Investment
Costs among the navigated patients declined a mean of $781.29 more per patient per quarter than among the nonnavigated patients, which could be estimated as a $475 024 reduction in cost annually for a navigator managing 152 patients throughout the year. For a navigator with an annual salary investment of $48 448 (salary and fringe benefits), we estimated a return on investment of 1:10.
Discussion
In this population of geriatric patients with cancer, we observed substantial reductions in resource use and cost for navigated patients in the PCCP compared with matched nonnavigated patients. This influence was observed for costs of hospitalizations, outpatient visits, and physician visits.
Figure 1. Study Population Exclusion Cascade
Despite clear benefits to patients from navigation, [10] [11] [12] [13] [14] [15] programs have struggled with sustainable methods because of a lack of financial support. The estimated potential 1:10 return on investment of the PCCP helps make a financial case to organizational leadership for sustainability of navigation programs. The observed benefit is likely because of the PCCP approach of targeting high-risk, high-cost patients and patients who have unmet needs, which is reflected in the differences observed between the navigated and nonnavigated patients in our study. Navigators are uniquely positioned to meet the needs of these high-risk patients and help them better use outpatient resources. Unlike physi- ED indicates emergency department; ICU, intensive care unit.
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Lay Navigation Support for Geriatric Patients With Cancer cians and nursing staff, navigators are not limited by the traditional model of clinic-based care. They engage patients during clinical encounters with health care professionals and between appointments through frequent telephone communication. 20 Navigators connect patients and their caregivers to appropriate resources across multiple disciplines, in different health care settings, and within the community at large. This patient-centered, preventive, proactive approach has the potential to lead to increased patient activation and earlier management of symptoms, decreasing the likelihood of unplanned admissions or inefficient care. 28-30 Our findings support this hypothesis.
While we observed cost declines across all use sources, costs increased for hospice use, which may be secondary to navigators facilitating earlier conversations about goals of care and care preferences. 20 The combination of reduced use of resources and increased hospice use achieved by the PCCP is consistent with other medical home, care transition, and palliative and supportive care interventions, which provide more appropriate support for patients with cancer, including those approaching the end of life. [31] [32] [33] The PCCP is a model of navigation that supports patients throughout the cancer care continuum and may be a mechanism to extend palliative and supportive care more fully into the community, particularly in rural areas that lack palliative care resources.
Limitations
There are several limitations to the interpretation of findings in our study. First, there was no random assignment to the PCCP and the comparison group, and high-risk patients were targeted for the PCCP enrollment. To minimize the differences in patient characteristics because of the lack of randomization and the targeting of high-risk patients for enrollment, we used propensity score matching and considered use before enrollment (or a pseudo-enrollment date for the comparison group). However, unmeasured confounding factors, such as patient social support and level of engagement in their health, may also influence the likelihood of navigation, as well as patient outcomes. The intensity of navigation services also varied by patient and by need, making it challenging to identify the benefit for individual patients. In addition, navigated patients often had missing cancer stage information, particularly in the initial phase of care, because the tumor registries lack real-time case abstraction.
Second, the 12 institutions shared data, continuously monitored claims-based outcomes, and received reports and education by the PCCP leadership team based on navigatorcollected and claims data. 20 The creation of this learning collaborative may have influenced cost and resource use declines because of local culture shifts that occurred as a result of the PCCP. Although culture change was not systematically evaluated, the UAB leadership team received anecdotal reports of health systems changing telephone protocols, adding same-day sick visits, and redirecting charitable contributions to navigator-identified patient needs. Third, the long-term influence of the Patient Protection and Affordable Care Act on health care use and cost is yet to be determined. Analysis of trends in health care spending suggests that costs are rising less rapidly, but reductions in cost have not been reported nationally. 34 To attempt to address this limitation, we adjusted for calendar time in our regression models. Even with the encouraging cost trends reported herein, the PCCP is not sustainable within the current fee-for-service payment model, which does not reward coordination of care. change in payment models appear to be upon us.
Conclusions
There was a significant decline in costs and resource use for navigated geriatric patients with cancer within the PCCP compared with matched nonnavigated patients. Overall, cost reductions were driven by substantial declines in hospitalizations and clinic-based services. This model has the potential to reach the Triple Aim 2 of improved health care, better health, and lower costs and significantly enhanced health care delivery in the United States as health systems transition to valuebased health care. What do patient navigators do that makes them so important? As described in the article by Rocque et al, 5 navigators identify barriers to care that each patient has and help resolve those barriers so that patients can get the care they need on time and adhere to medication regimens to stay out of the emergency department and hospital. In the example of breast cancer, as described by Daly and Olopade, 7 PN can address patterns of care, mainly access to timely, appropriate care that is essential to reducing cancer health disparities. In addition, and this point cannot be overemphasized, navigators often have more time to spend with patients than physicians, physician assistants, and nurse practitioners do and are trained in skills that these care professionals may not possess. Therefore, having navigators in the health care team can increase efficiency and address more broad causes for cancer health disparities.
With the strong evidence from many well-designed studies of PN, the latest being this large study by Rocque et al, 5 there is little doubt that PN is effective in terms of cost savings and health outcomes. 
